Surveillance And Analysis Of Avian Influenza Viruses In Wild Birds In Australia
Funder
National Health and Medical Research Council
Funding Amount
$250,237.00
Summary
Birds are commonly infected with bird flu viruses but most of these viruses do not cause disease. However, certain types of bird flu viruses, such as the H5N1 strain, can cause severe illness and death in 100% of infected birds. There is currently an epidemic of H5N1 bird flu occurring in Asia. Occasionally humans become infected by bird to human transmission and since 2003, 130+ people have been infected with H5N1 resulting in 60+ deaths. There are 3 ways in which dangerous strains of the virus ....Birds are commonly infected with bird flu viruses but most of these viruses do not cause disease. However, certain types of bird flu viruses, such as the H5N1 strain, can cause severe illness and death in 100% of infected birds. There is currently an epidemic of H5N1 bird flu occurring in Asia. Occasionally humans become infected by bird to human transmission and since 2003, 130+ people have been infected with H5N1 resulting in 60+ deaths. There are 3 ways in which dangerous strains of the virus may be brought to Australia by; infected people, domestic birds and migratory wading birds. In order to monitor the import of these viruses by migratory birds we will catch and take samples from large numbers of these birds in important areas where they congregate close to humans and poultry farms. We will identify what types of bird flu viruses these birds are carrying and if the viruses are capable of causing disease in birds and humans. We will also see if they can be treated by the influenza drugs that we currently have and we will study these viruses to find new drug targets. These viruses are commonest in ducks. Migratory wading birds and local ducks live in the same habitats so there is the chance that the wading birds and ducks could pass the viruses to each other. There is an additional concern that non-disease causing viruses could mutate in ducks and become pathogenic and pass from bird to bird or even human to human transmission which could cause a major human epidemic of bird flu in Australia. So we will also take samples from local ducks that occur in the same areas as the wading birds and test them for viruses as well. Our results will show what kinds of viruses are being carried by wading birds and ducks and if these viruses are a danger to people and poultry. We can then manage important areas so that humans and poultry do not come into contact with these viruses.Read moreRead less
Assessment Of Alpha-galactosylceramide As A Novel Adjuvant For Pandemic Influenza: A Virua Vaccine
Funder
National Health and Medical Research Council
Funding Amount
$220,042.00
Summary
The occurrence of human infections with pathogenic avian H5N1 Influenza A viruses was the first documentation of these viruses demonstrating an ability to directly transmit from birds to humans. The virulent nature of these infections, and the fact that there is no pre-existing immunity to these viruses in the human population has raised the concern that these viruses may emerge to cause the next influenza pandemic. Vaccination is our most effective way of protecting against influenza infection, ....The occurrence of human infections with pathogenic avian H5N1 Influenza A viruses was the first documentation of these viruses demonstrating an ability to directly transmit from birds to humans. The virulent nature of these infections, and the fact that there is no pre-existing immunity to these viruses in the human population has raised the concern that these viruses may emerge to cause the next influenza pandemic. Vaccination is our most effective way of protecting against influenza infection, however there are no commercially available avian influenza vaccines available. Moreover, recent evidence suggests current vaccines strategies may be less than effective. This proposal aims to evaluate the efficacy of a novel vaccine strategy that promotes immune protection against a potential pandemic influenza strain.Read moreRead less
Neonatal Immunization With Pneumococcal Conjugate Vaccine In Papua New Guinea
Funder
National Health and Medical Research Council
Funding Amount
$1,181,966.00
Summary
One million children die every year of pneumococcal (Pnc) disease, the majority in the third world. Many die in early infancy and babies may benefit from immunisation with a Pnc conjugate vaccine (PrevenarTM) at birth. The Papua New Guinea (PNG) Insatiate of Medical Research; Telethon Institute for Child Health Research and the Department of Paediatrics, University of Western Australia, will collaborate to closely examine the safety of this approach, particularly with regard to impact on the dev ....One million children die every year of pneumococcal (Pnc) disease, the majority in the third world. Many die in early infancy and babies may benefit from immunisation with a Pnc conjugate vaccine (PrevenarTM) at birth. The Papua New Guinea (PNG) Insatiate of Medical Research; Telethon Institute for Child Health Research and the Department of Paediatrics, University of Western Australia, will collaborate to closely examine the safety of this approach, particularly with regard to impact on the development of immunity and response to other vaccines given to infants. This study will also provide a unique opportunity for training of PNG and Australian scientists in both countries; transfer state-of-the-art immunological technology and stimulate further collaborations on respiratory infections in the region.Read moreRead less
HIV infection of CD4+ lymphocytes leads to a high rate of reproduction of new virus. However, in the brain, HIV infection of the astrocytes does not yield high levels of new virus. HIV is genetically active in these astrocytes, producing high levels of the messenger molecules, the so-called mRNA, that code for the proteins required for a new virus particle. We have determined that these HIV mRNAs are specifically prevented from translating into protein. The mechanisms controlling protein transla ....HIV infection of CD4+ lymphocytes leads to a high rate of reproduction of new virus. However, in the brain, HIV infection of the astrocytes does not yield high levels of new virus. HIV is genetically active in these astrocytes, producing high levels of the messenger molecules, the so-called mRNA, that code for the proteins required for a new virus particle. We have determined that these HIV mRNAs are specifically prevented from translating into protein. The mechanisms controlling protein translation from RNA are relatively poorly understood compared with the other control points of cellular gene expression, such as the synthesis of mRNA. This project examines how astrocytes rapidly detect the presence of HIV mRNA and alter their translation machinery to halt the expression of HIV protein. This host defence mechanism involves two key components; the cellular component that identifies and responds to the viral mRNA, and the structural features of the HIV mRNA that enable the cell to detect its viral origin. We will study how translation of HIV proteins requires both HIV and cellular factors. We will determine the impact of both viral RNA elements and viral RNA binding proteins on the translation of viral and cellular proteins. The contribution of the type-1 interferons that are produced in response to viral infection will be studied for their role in augmenting the inhibition of HIV protein translation. Since HIV infected astrocytes significantly contribute to the onset of AIDS dementia, we will sees a strategy to lock HIV into a dormant state in the brain and thereby prevent the neurodegenerative disease associated with HIV. We will use the anti-viral mechanism blocking HIV protein translation in astrocytes to protect other cell populations, such as the CD4+ lymphocytes, from HIV infection. These studies will also give insights into the general mechanisms for translational control of gene expression in human cells.Read moreRead less